Muscadvance (Diclofenac Potassium)

Diclofenac potassium blocks the cyclooxygenase (COX‑1 and COX‑2) enzymes, which are essential for producing prostaglandins. By lowering prostaglandin levels, the drug reduces inflammation, pain signaling, and fever at the site of injury.

The appropriate dose of Muscadvance is determined by the prescribing healthcare professional based on the patient’s condition, age, weight, and renal or hepatic function. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Diclofenac potassium is generally classified as a pregnancy‑category drug that should be avoided, especially in the third trimester, unless the benefits outweigh the risks. It is also excreted in breast milk, so use during lactation should be discussed with a physician.

To request Muscadvance, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Muscadvance (diclofenac potassium) offers rapid oral absorption and potent anti‑inflammatory activity, often comparable to ibuprofen or naproxen. Its potassium salt form may provide faster onset of pain relief, but safety profiles—including gastrointestinal and cardiovascular risks—are similar across the NSAID class.

Muscadvance should be stored at ambient temperature below 25 °C, in its original packaging, and protected from moisture and direct sunlight to maintain stability and potency.

Muscadvance is taken orally, usually with a full glass of water. It may be taken with or without food, but patients who experience stomach upset are advised to take it with meals or an antacid as directed by their healthcare provider.

Serious risks include gastrointestinal ulceration or bleeding, severe liver injury, renal impairment, cardiovascular events such as heart attack or stroke, and rare but life‑threatening skin reactions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they notice any of these symptoms.

Muscadvance should be avoided in individuals with known hypersensitivity to diclofenac or other NSAIDs, those with active gastrointestinal ulceration, severe heart failure, uncontrolled hypertension, significant liver or kidney disease, and in the later stages of pregnancy unless specifically advised by a physician.